SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-121768
Filing Date
2008-05-23
Accepted
2008-05-23 16:02:03
Documents
6
Period of Report
2008-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 24834
2 UNDERWRITING AGREEMENT, DATED MAY 20, 2008 dex11.htm EX-1.1 131463
3 OFFICERS' CERTIFICATE OF AMGEN INC. DATED AS OF MAY 23, 2008 dex42.htm EX-4.2 124170
4 OPINION OF LATHAM & WATKINS LLP, DATED MAY 23, 2008. dex51.htm EX-5.1 16407
5 GRAPHIC g83541img001.jpg GRAPHIC 2445
6 GRAPHIC g83541img002.jpg GRAPHIC 1954
  Complete submission text file 0001193125-08-121768.txt   305003
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 08858320
SIC: 2836 Biological Products, (No Diagnostic Substances)